4556.T
KAINOS Laboratories,Inc.
スタンダード · 医薬品 · 医薬品 · JP
JPY 2,268.00
+0.00%Year over year
Reported trailing growth
- Revenue
- +2.6%
- EBITDA
- —
- EBIT
- +0.9%
- EPS
- +8.5%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +0.8%
- EBITDA
- —
- EPS
- +0.5%
Three-year CAGR
- Revenue
- +4.8%
- EBITDA
- +1.1%
- EBIT
- +3.3%
- Net income
- +7.8%
- EPS
- +6.4%
- Free cash flow
- +11.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026